Denver, CO, United States
Denver, CO, United States

Time filter

Source Type

News Article | May 10, 2017
Site: www.prweb.com

Peranich Huffman Net Lease Group, a commercial real estate investment services firm that specializes in the brokerage and sale of net leased healthcare properties, announced the sale of the 18,600 square-foot multi-tenant medical office building located at 217 Sterling Drive. Constructed in 2009, the 100% occupied building is tenanted by DaVita Dialysis, DaVita Lifeline Access Center, and West Tennessee Kidney Specialists. The property’s anchor tenant, DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of December 31, 2016, DaVita Kidney Care operates over 2,350 outpatient dialysis centers, serving approximately 188,000 patients throughout the United States. “We continue to see a growing demand for recession-proof assets such as this,” said Nathan Huffman, managing partner of Peranich Huffman. “Given the historical retention rates of national dialysis providers such as DaVita and Fresenius, the net lease community recognizes this product type as a stable, low-risk investment.“ Within the past six months, Peranich Huffman has successfully brokered the sale of 13 dialysis facilities, with an aggregate value of approximately $32 million. Peranich Huffman Net Lease Group (“PHNLG”) is a Commercial Real Estate Brokerage firm that exclusively specializes in the brokerage and sale of net leased healthcare related real estate for physician groups, developers, and third party investors throughout the country. Since the inception of their partnership in 2014, the firm's managing partners have facilitated more transactions tenanted by national End Stage Renal Disease (ESRD) providers than any other brokerage firm in the country. To learn more, visit phnlg.com or call (832) 602-3383.


News Article | May 12, 2017
Site: www.prnewswire.com

Research shows that people with chronic medical conditions, such as chronic kidney disease, have a higher risk of depression, a common, but serious, mood disorder. If left untreated, depression may lead to a complication of chronic health conditions, reduced quality of life and increased risk of mortality. "It is important to understand the significant role that mental health plays in an individual's overall health and know when certain behaviors are potentially signs of something more," said Duane Dunn, director of social work services at DaVita. "We need to bring awareness to the benefits of intervention and how integrated services work to help those who are struggling with mental illness." DaVita social workers screen patients for depression twice a year in an effort to ensure patients are receiving the best possible quality of care and living the highest quality of life. The Everett Clinic, a DaVita Medical Group, offers several support groups and workshops designed to help patients suffering from mental illnesses. These offerings range from a Teen Skills Group, offering help to youth with mental illness, to a Living with Chronic Conditions workshop. About DaVita Inc. DaVita Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and DaVita Medical Group. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of March 31, 2017, DaVita Kidney Care operated or provided administrative services at 2,382 outpatient dialysis centers located in the United States serving approximately 189,400 patients. The company also operated 162 outpatient dialysis centers located in 11 countries outside the United States. DaVita Medical Group manages and operates medical groups and affiliated physician networks in California, Colorado, Florida, Nevada, New Mexico, Pennsylvania and Washington in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. As of December 31, 2016, DaVita Medical Group's teammates, employed clinicians and affiliated clinicians provided care for approximately 1.7 million patients. For more information, please visit DaVita.com/about. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/davita-helps-raise-awareness-of-mental-illness-during-mental-health-month-300456979.html


Prior to GRO, Hughson was President and CEO of IntegraMed Fertility, the largest fertility network in North America with 28 practices and 175 reproductive endocrinologists. There, he gained firsthand experience in working effectively with individual practices to combine a commitment to clinical excellence with a focus on patient experience, resulting in consistent delivery of double-digit growth rates. Hughson has also held leadership positions with DeVry Education Group, a leading global provider of educational services, and DaVita, a Fortune 500 provider of dialysis and related services. Hughson is currently a member of the board of directors at IntegraMed Fertility and GRO. "Last year, we served more patients than ever before, thanks to GRO's excellent team and strong reputation for providing great care. As we move into our 36th year, Bill's experience will take GRO to its next phase of growth so we can continue to support our doctors with the additional resources, new technologies, and exceptional staff they need to be successful as more patients demand more services," said Dr. Phil Vanderlugt, an optometrist at GRO. "It's clear that GRO's longevity, the quality of its doctors and staff, and its recent partnership with Great Lakes MSO have uniquely positioned GRO to rapidly and strategically grow, and provide the best patient care to individuals and families throughout West Michigan," said Hughson. "I look forward to working with the GRO team as we begin our next chapter." In February, GRO joined Great Lakes MSO, a practice management services organization formed by Sterling Partners, to further its growth through Great Lakes' resources, management team, and capital. If you are interested in learning more about a partnership with Great Lakes MSO, contact Dan Hosler at dhosler@seeitclear.com. About Grand Rapids Ophthalmology Grand Rapids Ophthalmology provides experienced professionals including 11 ophthalmologists and 18 optometrists at locations throughout West Michigan to offer convenient and easy access to professional care. GRO's mission is to provide a broad spectrum of high-quality, state-of-the-art eye care, products, and services with the highest ethical standards and with unrivaled service to patients. GRO further strives to provide its patients, staff, and doctors with an outstanding work environment. For more information, visit: www.seeitclear.com. About Sterling Partners Sterling Partners is a private equity firm with a distinct point of view on how to build great companies. Founded in 1983, Sterling is guided by its stated purpose, INSPIRED GROWTH®, which describes Sterling's approach to investing in differentiated businesses and growing them in inspired ways. Sterling focuses on investing growth capital in middle-market companies in the healthcare services and business services industries. Sterling provides valuable support to the management teams of the companies in which the firm invests through a deep and dedicated team of professionals, including a strong network of outside directors and advisors. The people at Sterling believe in ideas and ideals, in people and in partnerships that drive long-term success. For more information, visit: www.sterlingpartners.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/grand-rapids-ophthalmology-names-bill-hughson-as-ceo-to-support-accelerated-growth-throughout-west-michigan-300456111.html


The "Transformation 10" Goes Beyond Celebrated Tech Companies, Says Innosight LEXINGTON, MA--(Marketwired - May 9, 2017) - As the pace of change accelerates in virtually every industry, a new study has identified the 10 global companies that have done the best job of remaking their businesses. The list -- which includes celebrated tech innovators like Amazon and Netflix as well as standouts from industries that don't as frequently make innovation headlines, including health care company DaVita and food and beverage giant Danone -- offers insights into how market leaders can sustain growth even as disruption threatens their historically successful core business. The Transformation 10, a new report by growth strategy consulting firm Innosight, analyzed 1,000 companies and engaged a panel of business leaders to identify the 10 companies whose transformations had the biggest impact on their respective industries and the most potential to be sustained. The judges included former P&G CEO A.G. Lafley, former Boeing Defense CEO Chris Chadwick, and Columbia business professor Rita Gunther McGrath. Online retailer Amazon and entertainment firm Netflix were tied atop the rankings, followed (in order) by travel-technology company Priceline; global tech firm Apple; health insurer Aetna; software company Adobe; health care firm DaVita; computer and software maker Microsoft; food and beverage company Danone; and steel maker ThyssenKrupp. "A company survives and thrives over time based not on its size at any given time, but on its ability to adapt to disruption and to reposition itself to create a new future. We believe that by identifying companies that are transforming successfully, we can gain a better understanding of the dynamics and success factors of transformation," notes Innosight managing partner Scott Anthony, who is the co-author of the just-released Dual Transformation: How to Reposition Today's Business While Creating the Future (Harvard Business Review Press). Each company in the Transformation 10 found a way to create new growth while repositioning its traditional business: 1. Online retail giant Amazon developed technology to streamline internal operations, then turned it into a cloud computing platform that Amazon began selling to outside customers as large as the U.S. government. Since beginning what is now Amazon Web Services (AWS) in 2006, the new growth area now delivers about 10% of revenue, and accounted for more than half of Amazon's operating profit in 2015. At the same time, Amazon has steadily fortified its core online retail business with new categories, including a growing library of music, movies and original programming. 2. Video entertainment company Netflix began shifting its business model to include on-demand streaming as well as traditional hard-copy DVD rentals in 2007. That core business of hard-copy rentals continues to exist, albeit in a diminished state. Meanwhile, Netflix's domestic and international streaming business posted almost 90% of the firm's revenue in 2015, and the company has been producing and commissioning its own content since 2013, another potential source of growth. 3. Travel-technology company Priceline was already the world leader in online travel in 2010, when it decided to provide a more complete service that included the "long tail" of travel suppliers beyond the major hotels (e.g., independent hotels, apartment buildings). To capture that new growth, Priceline acquired companies like Bookings.com and KAYAK, and the new growth business generated about 25% of revenue in 2015. Simultaneously, Priceline recalibrated its core business around helping customers plan a complete travel experience -- much like an online concierge. 4. Beginning in 2007, computer giant Apple moved beyond its successful computer hardware business to create the world's biggest ecosystem for digital content -- and then to build on that ecosystem with new devices like the iPhone. Apple continues to be a manufacturer of computers, but the revenue from the firm's digital networks and related products now accounts for 80% of the company. 5. Health insurer Aetna's traditional model of selling health insurance through employers has grown nearly 80% over the last four years. Starting in 2010, the firm also began selling care management directly to consumers, and health care IT services to providers. Revenue from these newer, "value-based" contracts now accounts for about 40% of overall firm revenue. 6. Software company Adobe dominated the market for creating and designing documents and images, thanks to brands like Photoshop, Illustrator and Acrobat. But by 2008, fearing a saturated user base and a shift to cloud-based business models, the firm announced a new focus on digital marketing and analytics through a software as a service (SaaS) business model. The core business of packaged creative software lives on as the Creative Cloud subscription service, and new growth through digital marketing now creates almost half (45%) of overall revenue. 7. Health care firm DaVita specialized in kidney dialysis, making its money on a traditional fee-for-service business model and becoming one of the largest operators in its field. But starting in 2012, DaVita began building an "integrated delivery network" to deliver dialysis care as well as manage patients' total healthcare. The core business -- dialysis care -- has nearly doubled over the last 10 years, while new growth now delivers 30% of total revenue. 8. Computer firm Microsoft continues to sell hardware and software; its legacy business offering still accounts for about half the company. But, starting in 2010, the firm made a bet on embracing cloud-based technology -- while building up its hardware business. Its Intelligent Cloud business, which includes Azure and on-premises server software, reported 2016 revenue of more than $25 billion, almost a third (32%) of the company total. 9. French food and beverage firm Danone moved beyond its traditional yogurt business to grow a portfolio of health brands, including baby foods and other early life nutrition products. Those newer brands now generate 29% of Danone's revenue, up from just 3% in 2006. At the same time, a slimmed-down core business, refocused on healthy yogurts and other nutritional foods, is still profitable and accounts for the majority of the business. 10. German steel maker ThyssenKrupp, under pressure from low-cost producers in Asia, decided to move drastically away from making and selling steel. Instead, in 2012 the firm began investing in industrial solutions, providing capital equipment, software and services to manufacturers, including refineries and automakers. The new growth area already accounts for 47% of total company revenue. The Transformation 10 report highlights a few takeaways and lessons that can help business leaders respond to market disruption and position their companies for the future, including: The research focused on 57 companies from the S&P 500 and Global 500 that had made significant public commitments to transformation. The analysis evaluated public companies through three lenses: new growth, success in repositioning the core, and select financial metrics. To assess areas of new growth, Innosight measured how successful these companies have been at creating new products, services, markets and business models, and in that process determined the percent of revenue that can be attributed to new growth areas. To measure success in repositioning the core business, Innosight examined how effectively these companies adapted their traditional businesses to changes or disruptions in their markets. The financial metrics that Innosight analyzed combined annual growth rate (CAGR) of each company's revenue and stock price, as well as overall profitability, during their respective transformation periods. After narrowing down to a list of 18 companies, Innosight worked with a panel of business leaders to identify the 10 companies whose transformations had the biggest impact on their respective industries and the most potential to be sustained. The judges were: Chris Chadwick, former CEO, Boeing Defense; Clay Christensen, Professor, Harvard Business School and Innosight co-founder; Scott Cook, Founder and Chairman of Intuit; Matthew Eyring, Chief Strategy and Innovation Officer at Vivint; A.G. Lafley, former CEO of Procter & Gamble; Rita McGrath, Professor, Columbia Business School; Teo Ming Kian, Director Temasek and Chairman Vertex Holdings; Theodor Weimer, Country Chairman, UniCredit. To read the Transformation 10 report, please visit: www.transformationten.com ABOUT INNOSIGHT Innosight, the strategy and innovation business of global professional services firm Huron, helps organizations design and create the future, instead of being disrupted by it. Acquired by Huron in 2017, Innosight is the leading authority on disruptive innovation and strategic transformation. The company collaborates with clients across a range of industries to identify new growth opportunities, build new ventures and capabilities, and accelerate organizational change. Learn more at www.innosight.com and www.huronconsultinggroup.com.


The "Transformation 10" Goes Beyond Celebrated Tech Companies, Says Innosight LEXINGTON, MA--(Marketwired - May 9, 2017) - As the pace of change accelerates in virtually every industry, a new study has identified the 10 global companies that have done the best job of remaking their businesses. The list -- which includes celebrated tech innovators like Amazon and Netflix as well as standouts from industries that don't as frequently make innovation headlines, including health care company DaVita and food and beverage giant Danone -- offers insights into how market leaders can sustain growth even as disruption threatens their historically successful core business. The Transformation 10, a new report by growth strategy consulting firm Innosight, analyzed 1,000 companies and engaged a panel of business leaders to identify the 10 companies whose transformations had the biggest impact on their respective industries and the most potential to be sustained. The judges included former P&G CEO A.G. Lafley, former Boeing Defense CEO Chris Chadwick, and Columbia business professor Rita Gunther McGrath. Online retailer Amazon and entertainment firm Netflix were tied atop the rankings, followed (in order) by travel-technology company Priceline; global tech firm Apple; health insurer Aetna; software company Adobe; health care firm DaVita; computer and software maker Microsoft; food and beverage company Danone; and steel maker ThyssenKrupp. "A company survives and thrives over time based not on its size at any given time, but on its ability to adapt to disruption and to reposition itself to create a new future. We believe that by identifying companies that are transforming successfully, we can gain a better understanding of the dynamics and success factors of transformation," notes Innosight managing partner Scott Anthony, who is the co-author of the just-released Dual Transformation: How to Reposition Today's Business While Creating the Future (Harvard Business Review Press). Each company in the Transformation 10 found a way to create new growth while repositioning its traditional business: 1. Online retail giant Amazon developed technology to streamline internal operations, then turned it into a cloud computing platform that Amazon began selling to outside customers as large as the U.S. government. Since beginning what is now Amazon Web Services (AWS) in 2006, the new growth area now delivers about 10% of revenue, and accounted for more than half of Amazon's operating profit in 2015. At the same time, Amazon has steadily fortified its core online retail business with new categories, including a growing library of music, movies and original programming. 2. Video entertainment company Netflix began shifting its business model to include on-demand streaming as well as traditional hard-copy DVD rentals in 2007. That core business of hard-copy rentals continues to exist, albeit in a diminished state. Meanwhile, Netflix's domestic and international streaming business posted almost 90% of the firm's revenue in 2015, and the company has been producing and commissioning its own content since 2013, another potential source of growth. 3. Travel-technology company Priceline was already the world leader in online travel in 2010, when it decided to provide a more complete service that included the "long tail" of travel suppliers beyond the major hotels (e.g., independent hotels, apartment buildings). To capture that new growth, Priceline acquired companies like Bookings.com and KAYAK, and the new growth business generated about 25% of revenue in 2015. Simultaneously, Priceline recalibrated its core business around helping customers plan a complete travel experience -- much like an online concierge. 4. Beginning in 2007, computer giant Apple moved beyond its successful computer hardware business to create the world's biggest ecosystem for digital content -- and then to build on that ecosystem with new devices like the iPhone. Apple continues to be a manufacturer of computers, but the revenue from the firm's digital networks and related products now accounts for 80% of the company. 5. Health insurer Aetna's traditional model of selling health insurance through employers has grown nearly 80% over the last four years. Starting in 2010, the firm also began selling care management directly to consumers, and health care IT services to providers. Revenue from these newer, "value-based" contracts now accounts for about 40% of overall firm revenue. 6. Software company Adobe dominated the market for creating and designing documents and images, thanks to brands like Photoshop, Illustrator and Acrobat. But by 2008, fearing a saturated user base and a shift to cloud-based business models, the firm announced a new focus on digital marketing and analytics through a software as a service (SaaS) business model. The core business of packaged creative software lives on as the Creative Cloud subscription service, and new growth through digital marketing now creates almost half (45%) of overall revenue. 7. Health care firm DaVita specialized in kidney dialysis, making its money on a traditional fee-for-service business model and becoming one of the largest operators in its field. But starting in 2012, DaVita began building an "integrated delivery network" to deliver dialysis care as well as manage patients' total healthcare. The core business -- dialysis care -- has nearly doubled over the last 10 years, while new growth now delivers 30% of total revenue. 8. Computer firm Microsoft continues to sell hardware and software; its legacy business offering still accounts for about half the company. But, starting in 2010, the firm made a bet on embracing cloud-based technology -- while building up its hardware business. Its Intelligent Cloud business, which includes Azure and on-premises server software, reported 2016 revenue of more than $25 billion, almost a third (32%) of the company total. 9. French food and beverage firm Danone moved beyond its traditional yogurt business to grow a portfolio of health brands, including baby foods and other early life nutrition products. Those newer brands now generate 29% of Danone's revenue, up from just 3% in 2006. At the same time, a slimmed-down core business, refocused on healthy yogurts and other nutritional foods, is still profitable and accounts for the majority of the business. 10. German steel maker ThyssenKrupp, under pressure from low-cost producers in Asia, decided to move drastically away from making and selling steel. Instead, in 2012 the firm began investing in industrial solutions, providing capital equipment, software and services to manufacturers, including refineries and automakers. The new growth area already accounts for 47% of total company revenue. The Transformation 10 report highlights a few takeaways and lessons that can help business leaders respond to market disruption and position their companies for the future, including: The research focused on 57 companies from the S&P 500 and Global 500 that had made significant public commitments to transformation. The analysis evaluated public companies through three lenses: new growth, success in repositioning the core, and select financial metrics. To assess areas of new growth, Innosight measured how successful these companies have been at creating new products, services, markets and business models, and in that process determined the percent of revenue that can be attributed to new growth areas. To measure success in repositioning the core business, Innosight examined how effectively these companies adapted their traditional businesses to changes or disruptions in their markets. The financial metrics that Innosight analyzed combined annual growth rate (CAGR) of each company's revenue and stock price, as well as overall profitability, during their respective transformation periods. After narrowing down to a list of 18 companies, Innosight worked with a panel of business leaders to identify the 10 companies whose transformations had the biggest impact on their respective industries and the most potential to be sustained. The judges were: Chris Chadwick, former CEO, Boeing Defense; Clay Christensen, Professor, Harvard Business School and Innosight co-founder; Scott Cook, Founder and Chairman of Intuit; Matthew Eyring, Chief Strategy and Innovation Officer at Vivint; A.G. Lafley, former CEO of Procter & Gamble; Rita McGrath, Professor, Columbia Business School; Teo Ming Kian, Director Temasek and Chairman Vertex Holdings; Theodor Weimer, Country Chairman, UniCredit. To read the Transformation 10 report, please visit: www.tranformationten.com ABOUT INNOSIGHT Innosight, the strategy and innovation business of global professional services firm Huron, helps organizations design and create the future, instead of being disrupted by it. Acquired by Huron in 2017, Innosight is the leading authority on disruptive innovation and strategic transformation. The company collaborates with clients across a range of industries to identify new growth opportunities, build new ventures and capabilities, and accelerate organizational change. Learn more at www.innosight.com and www.huronconsultinggroup.com.


News Article | June 1, 2017
Site: www.prnewswire.com

Magan Medical Clinic's 55 providers serve more than 20,000 managed care patients. The medical group offers primary care as well as a wide range of specialty care services including cardiology, dermatology, endocrinology, neurology and oncology. "Over multiple generations, Magan Medical Clinic has been proud to serve the communities of Covina, West Covina, San Dimas, Diamond Bar and La Verne," said Dr. Bradley Rosenberg, president of Magan Medical Clinic. "We chose to join HealthCare Partners, part of the nationally renowned DaVita Medical Group, so that together we could achieve even better care for generations to come. This is an exciting step in our growth and our mission to provide great patient care." The transaction is expected to close by mid-2017 subject to completion of due diligence and other customary closing conditions. DaVita Medical Group is a division of DaVita Inc., a Fortune 500® company that operates and manages medical groups and affiliated physician networks in California, Colorado, Florida, Nevada, New Mexico, Pennsylvania and Washington. A leading independent medical group in America, DaVita Medical Group has over two decades of experience providing coordinated, outcomes-based medical care in a cost-effective manner. As of December 31, 2016, DaVita Medical Group's teammates, employed clinicians and affiliated clinicians provided care for approximately 1.7 million patients. For more information, please visit healthcarepartners.com. DaVita Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and DaVita Medical Group. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of March 31, 2017, DaVita Kidney Care operated or provided administrative services at 2,382 outpatient dialysis centers located in the United States serving approximately 189,400 patients. The company also operated 162 outpatient dialysis centers located in 11 countries outside the United States. DaVita Medical Group manages and operates medical groups and affiliated physician networks in California, Colorado, Florida, Nevada, New Mexico, Pennsylvania and Washington in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. As of December 31, 2016, DaVita Medical Group's teammates, employed clinicians and affiliated clinicians provided care for approximately 1.7 million patients. For more information, please visit DaVita.com/about. Magan Medical Clinic, Inc. was founded in 1919 by Dr. W.P. Magan, Sr. The practice has been at its present address in Covina, Calif. since 1967, expanding to its current size in 1989, with additional satellite offices serving the communities of Diamond Bar, La Verne, San Dimas, West Covina, and surrounding cities. Magan Clinic proudly provides quality medical care as a multispecialty practice with many specialists under one roof, striving to help its patients lead a healthier lifestyle. For more information, please visit maganclinic.com. This release may contain forward-looking statements within the meaning of the federal securities laws. All statements that do not concern historical facts are forward-looking statements and include, among other things, statements about our expectations, beliefs, intentions and/or strategies for the future, including the prospective performance of or synergies created involving the acquired business, prospects for enhanced patient care, and the impact the business combination will have on clinical outcomes and growth in the number of patients served. Factors which could impact future results include the uncertainties associated with our ability to complete any acquisition or merger that we might be considering or announce, or integrate and successfully operate any business we may acquire, or retain key personnel of the acquired business or such personnel being able to continue to manage or have adequate resources to operate the acquired business successfully, and the other risk factors set forth in our SEC filings, including our Annual Report on Form 10-K for the year ended December 31, 2016, and subsequent quarterly reports filed on Form 10-Q. Any forward-looking statements should be considered in light of these risks and uncertainties. We base our forward-looking statements on information currently available to us at the time of this release, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of changes in underlying factors, new information, future events or otherwise. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/healthcare-partners-to-acquire-magan-medical-clinic-300466692.html


News Article | February 15, 2017
Site: www.prweb.com

DaVita Clinical Research (DCR), a specialty contract research organization with services spanning the full spectrum of drug and device development, and Prism Clinical Research, a leader in providing fully integrated clinical research services to pharma/device companies and clinicians, today announced Verified Clinical Trials (VCT) has been selected by both companies as an exclusive provider to further prevent duplicate enrollment in clinical trials. Simultaneously enrolling in multiple clinical trials, or duplicate enrollment, has become a serious problem in the clinical research world. A growing number of research volunteers attempt to jump from one study to another without waiting for the appropriate amount of time to lapse. This creates dangerous issues for the drug manufacturer, the research site, the data quality, and, most importantly, the volunteer. “We are pleased to have these two clinical research leaders join our network,” said Dr. Mitchell Efros, CEO of VCT. “Our system will allow both companies to take big steps forward in preventing duplicate enrollment and the risks associated.” VCT maintains a global clinical trial research subject database registry to counter attempts at duplicate enrollment in clinical trial research. The majority of phase I units and an increasingly large number of late phase sites in North America use Verified Clinical Trials, making VCT by far the largest North American clinical research subject database registry in both early and late phase clinical trials. “DCR is passionate about ensuring data quality and research subject safety,” said Amy Young, vice president and general manager of DCR. “Partnering with Prism and using the VCT system is the right thing to do for all our stakeholders.” Experts and leaders in the field of hepato-renal clinical trials, Prism and DCR join a vast network of research sites and pharmaceutical companies in their efforts to prevent duplicate enrollment and other important protocol violations in clinical trials. ”Prism is glad to be participating in this joint effort with our research neighbor, DCR,” said Jeff Cosgrove, president of Prism Research. “We’ve always been proactive in combating dual enrollment, but VCT gives us state-of-the-art technology and processes toward that end.” Located in close proximity to the Minneapolis and St. Paul metropolitan area, Prism and DCR specialize in early phase clinical research in healthy volunteer trials and many patient-based volunteer trials, including those in hepatic and renal insufficiency populations. About Prism Clinical Research Prism Clinical Research is a Twin Cities–based clinical research company committed to the advancement of improved medical knowledge and the community’s health. Since 2005, Prism has provided FDA-approved, investigational pharmaceutical and medical device testing services on behalf of drug and device manufacturers, academic and private physicians, as well as other researchers across Minnesota. About DaVita Clinical Research DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita Inc., uses its extensive, applied database and real-world healthcare experience to assist pharmaceutical and medical device companies in the design, recruitment and completion of retrospective, prospective and pragmatic clinical trials. DCR’s scientific and clinical expertise spans the lifecycle of product development with more than 175 client companies. DCR’s Early Clinical Research unit (Phase I-IIa) and Late Phase Clinical Research (Phase IIb through post-marketing) network of physicians and investigative sites, and Real World Healthcare Data are focused on providing world-class research in both complex/specialty populations and therapeutic areas, and especially in CKD and ESRD populations. To learn more about DCR, visit http://www.davitaclinicalresearch.com. About Verified Clinical Trials Verified Clinical Trials is a forward thinking company developed by experts active in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts duplicate enrollment in clinical trials and defines itself as the world’s leader in the field of database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry designed specifically to enhance the quality of both early and late phase trials, and has the scalability to reach all sites nationally as well as on a global level. Verified Clinical Trials offers numerous other value-added services to the clinical research site, CRO, and Pharmaceutical Sponsor that prove invaluable with regards to financial and legal issues and liabilities. Verified Clinical Trials prevents several other key protocol deviations. For more information, RSVP to or visit http://www.verifiedclinicaltrials.com.


News Article | February 21, 2017
Site: globenewswire.com

RADNOR, Pa., Feb. 21, 2017 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds DaVita Inc. (NYSE:DVA) (“DaVita” or the “Company”) shareholders that a class action lawsuit has been filed in the United States District Court for the District of Colorado against DaVita on behalf of purchasers of the Company’s securities between August 5, 2015 and October 21, 2016, inclusive (the “Class Period”).  Important Deadline Reminder:  DaVita shareholders who purchased their securities during the Class Period may, no later than April 3, 2017, petition the Court to be appointed as a lead plaintiff representative of the class.  For additional information or to learn how to participate in this action please visit https://www.ktmc.com/new-cases/davita-inc#join DaVita provides kidney dialysis services for patients suffering from chronic kidney failure or end-stage renal disease. At relevant times, DaVita made contributions to the American Kidney Fund (“AKF”), a purported charitable foundation that provides financial assistance toward patients’ health insurance premiums. The shareholder class action complaint alleges that DaVita and certain of its executive officers made a series of materially false and misleading statements and/or failed to disclose material adverse facts about the Company’s business, operations, and prospects to investors during the Class Period, including the following: (1) that the Company and its senior executives purposefully steered patients into unnecessary insurance plans in order to maximize profits; (2) that the Company was using AKF as a vehicle to facilitate these improper practices; (3) that, as a result, DaVita’s revenues and profits were illegally obtained; and (4) that DaVita lacked effective internal controls over financial reporting. The complaint further alleges that, as a result of the foregoing, the defendants’ statements about DaVita’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis. On August 18, 2016, The Centers for Medicare & Medicaid Services issued a public request for information regarding the alleged steering of Medicare and Medicaid beneficiaries into other plans in order to earn higher reimbursement rates. Following this news, shares of the Company’s stock declined $3.17 per share, or 4.7%, to close on August 19, 2016 at $64.48 per share. Then, on October 23, 2016, the St. Louis Post published an article entitled “DaVita encouraged some low-income patients to enroll in commercial plans” which directly accused DaVita of steering clients to private insurers and utilizing its own money to pay for health insurance premiums through the AKF.  Following this news, shares of the Company’s stock declined an additional $2.86 per share, or 4.7%, to close on October 24, 2016 at $58.10 per share. Subsequently, on January 6, 2017, The Wall Street Journal reported that investigators from the U.S. Department of Justice “are probing a controversial arrangement under which kidney-care companies support charitable efforts to help patients pay health-insurance premiums, according to disclosures from major dialysis providers.” Additionally, the article reported that the “Boston U.S. attorney’s office has subpoenaed DaVita Inc. … seeking ‘the production of information related to charitable premium assistance.’” If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check (Darren J. Check, Esq., D. Seamus Kaskela, Esq. or Adrienne O. Bell, Esq.) at (888) 299–7706 or (610) 667–7706, or via e-mail at info@ktmc.com. DaVita shareholders may, no later than April 3, 2017, petition the Court to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check or other counsel, or may choose to do nothing and remain an absent class member.  A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.  In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class in the action.  Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.  For additional information, or to learn how to participate in this action, please visit https://www.ktmc.com/new-cases/davita-inc#join Kessler Topaz Meltzer & Check prosecutes class actions in state and federal courts throughout the country. Kessler Topaz Meltzer & Check is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world.  The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars).  The complaint in this action was not filed by Kessler Topaz Meltzer & Check.  For more information about Kessler Topaz Meltzer & Check, please visit www.ktmc.com.


News Article | February 23, 2017
Site: www.prnewswire.com

DENVER, Feb. 23, 2017 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading independent medical group in America and leading provider of kidney care services, has selected Bryan Becker, M.D., MMM, FACP, CPE as chief medical officer of VillageHealth, a subsidiary of DaVita specializing in...


News Article | February 16, 2017
Site: www.prnewswire.com

DENVER, Feb. 16, 2017 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced results for the quarter and year ended December 31, 2016. Net income attributable to DaVita Inc. for the quarter and year ended December 31, 2016 was $158 million, or $0.80 per share and $880 million,...

Loading DaVita Inc collaborators
Loading DaVita Inc collaborators